Company news

Liquidia Corporation news in 2021

Liquidia Corporation's news releases, calls and decks from 2021, newest first.

View company

Stipulation of Partial Judgment In Favor of Liquidia Filed In Hatch-Waxman Litigation

December 28, 2021

Liquidia to Participate in the Jefferies London Healthcare Conference

November 10, 2021

FDA Grants Tentative Approval for Liquidia’s YUTREPIA™ (Treprostinil) Inhalation Powder

November 7, 2021

Liquidia Reports Third Quarter 2021 Financial Results and Provides Corporate Update

November 2, 2021

Liquidia to Participate at H.C. Wainwright 23rd Annual Global Investment Conference

September 9, 2021

FDA Completes On-site Pre-Approval Inspection of Liquidia’s Morrisville, North Carolina Facility

August 17, 2021

U.S. Patent Trial and Trademark Appeal Board Decides to Institute Inter Partes Review of United Therapeutics’ Tyvaso® Patent

August 11, 2021

Liquidia Reports Second Quarter 2021 Financial Results and Provides Corporate Update

August 9, 2021

Liquidia to Report Second Quarter 2021 Financial Results on August 10, 2021

August 2, 2021

Liquidia Announces FDA Acceptance of New Drug Application Resubmission for LIQ861 (treprostinil) Inhalation Powder

June 1, 2021

Liquidia Corporation To Present At The Jefferies Virtual Healthcare Conference

May 25, 2021

Liquidia Announces Generic Treprostinil Injection Now Also Available for Subcutaneous Route of Administration

May 23, 2021

Liquidia Reports First Quarter 2021 Financial Results and Provides Corporate Update

May 12, 2021

Liquidia Resubmits New Drug Application for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension

May 9, 2021

Liquidia Corporation to Report First Quarter 2021 Financial Results on May 13, 2021

May 5, 2021

Liquidia Corporation Announces $21.7 Million Private Placement

April 12, 2021

Liquidia Corporation To Present At The 20th Annual Needham Virtual Healthcare Conference

April 6, 2021

Liquidia Announces Generic Treprostinil Injection Will Be Available for Subcutaneous Route of Administration

March 29, 2021

Liquidia Corporation Reports Full-Year 2020 Financial Results and Provides Corporate Update

March 22, 2021

Liquidia Corporation to Host 2020 Financial Results Conference Call on March 23, 2021

March 8, 2021

Liquidia Corporation Secures $20.5 Million Debt Facility with Silicon Valley Bank

March 1, 2021

Calls in 2021